tunel staining kit (Servicebio Inc)
Structured Review

Tunel Staining Kit, supplied by Servicebio Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/tunel staining kit/product/Servicebio Inc
Average 90 stars, based on 1 article reviews
Images
1) Product Images from "PKM2 + apoptotic vesicle-mediated systemic senolytics ameliorate chronic periodontitis"
Article Title: PKM2 + apoptotic vesicle-mediated systemic senolytics ameliorate chronic periodontitis
Journal: Bioactive Materials
doi: 10.1016/j.bioactmat.2025.06.041
Figure Legend Snippet: Irreversible periodontitis leads to apoptotic resistance. ( a – c ) Western blotting was used to evaluate the Fas, Caspase 3, Cleaved caspase 3 (Cl-caspase 3), Bax, and Bcl-xl expression in the mouse spleen, bone marrow, and peripheral blood lymphocytes. ( d ) The expression of Cl-caspase 3 and Bax human peripheral blood lymphocytes was evaluated by Western blotting. ( e and f ) Mouse peripheral blood lymphocyte apoptotic rates, as determined by flow cytometry. (n = 4) ( g and h ) Human peripheral blood lymphocyte apoptotic rate was analyzed by flow cytometry. (n = 4) ( i and j ) IF staining and quantification of TUNEL in the spleen and femur. (n = 4) Scale bar, 50 μm. ( k ) The p65, p-p65, p16, and Bcl-xl expression of BMMSCs was evaluated by Western blotting. ( l and m ) SA-β-Gal staining was used to analyze senescence of BMMSCs. (n = 4) Scale bar, 50 μm. ( n and o ) Flow cytometry was used to determine the apoptotic rate of BMMSCs. (n = 4) For two-group comparisons, significance was assessed by unpaired Student's t -test. Error bars show the mean ± SD. ∗ P < 0.05, ∗∗ P < 0.01, ∗∗∗ P < 0.001. ns, not significant.
Techniques Used: Western Blot, Expressing, Flow Cytometry, Staining, TUNEL Assay
Figure Legend Snippet: The senolytics dasatinib and quercetin can reverse alveolar bone loss in CP mice. ( a ) Representative microCT 3-dimensional reconstructed images of maxillae and HE staining on maxilla sections in CP mice. Ctrl: Normal mice without any treatment, used as baseline controls, Veh: CP mice treated with vehicle solution (10 % polyethylene glycol 4000), D + Q: CP mice treated with dasatinib (5 mg/kg body mass) and quercetin (50 mg/kg body mass), Scale bar, 0.4 μm (microCT), 200 μm (HE). ( b ) Quantification of alveolar bone loss, represented by measurement of palatal CEJ-ABC area (red line surrounding area). (n = 4–5) ( c and d ) TRAP staining showed a reduction in osteoclasts (stained in red) in the D + Q group compared to the vesicle control (Veh) group. (n = 3) Scale bar, 20 μm. ( e ) ELISA showed proinflammatory cytokines IL-17, IL-1β, TNF-α, TNF-β, IFN-γ, and IL-6 in the plasma. D + Q significantly reduced TNF-β and IFN-γ levels in periodontitis mice. (n = 4) ( f – i ) IF staining of p16 and SA-β-Gal staining revealed that D + Q reduced the accumulation of senescent cells in the liver, spleen, kidney, and femur. (n = 4) Scale bar, 10 μm (IF), 50 μm (β-Gal). ( j and k ) IF staining and quantification of TUNEL in the spleen and femur. (n = 4) Scale bar, 50 μm. Differences among three groups were analyzed by one-way ANOVA with Tukey's post hoc test. Error bars show the mean ± SD. ∗ P < 0.05, ∗∗ P < 0.01, ∗∗∗ P < 0.001. ns, not significant.
Techniques Used: Staining, Control, Enzyme-linked Immunosorbent Assay, Clinical Proteomics, TUNEL Assay
Figure Legend Snippet: MSC-apoV and MSC infusion ameliorates local alveolar bone loss and systemic inflammation in periodontitis mice. ( a and b ) Representative microCT 3-dimensional reconstructed images of maxillae and HE staining on maxilla sections showed that both MSC-apoV and MSC infusion could promote alveolar bone repair. The data points represent measurements from both the left and right sides of each mouse. Due to unsuccessful sample collection, some mice contributed data from only one side, which creates a sample size that seems to be less than 4 in the illustration. This has been clarified to avoid confusion. PBS: CP mice treated with PBS, MSCs:CP mice treated with MSCs, ApoVs: CP mice treated with MSC-apoVs, (n = 4–5) Scale bar, 0.4 mm (microCT), 1000 μm (HE). ( c and d ) TRAP staining showed more osteoclasts (stained in red) in the PBS group compared to the MSC-apoV and MSC groups. (n = 3) Scale bar, 20 μm. ( e ) HE staining demonstrated that MSC-apoVs and MSCs rescued pathological changes in the liver, spleen, kidney, and femur. Scale bar, 50 μm. ( f – i ) MSC-apoVs and MSCs decreased senescent cells in the liver, spleen, kidney, and femur, which were analyzed by SA-β-Gal staining and p16 IF staining. (n = 4) Scale bar, 50 μm (β-Gal), 10 μm (IF). ( j and k ) TUNEL staining was used to evaluate the apoptotic levels in the spleen and bone marrow. Both MSC-apoVs and MSCs promoted apoptosis in these tissues. (n = 4) Differences among three groups were analyzed by one-way ANOVA with Tukey's post hoc test. Scale bar, 50 μm. Error bars show the mean ± SD. ∗ P < 0.05, ∗∗ P < 0.01, ∗∗∗ P < 0.001. ns, not significant.
Techniques Used: Staining, TUNEL Assay
Figure Legend Snippet: PKM2 is responsible for MSC-apoV-mediated amelioration of local alveolar bone loss and systemic inflammation in periodontitis mice. ( a ) Representative microCT 3-dimensional reconstructed images of maxillae and HE staining on maxilla sections showed that PKM2 + MSC-apoV infusion could promote alveolar bone repair, while PKM2 low MSC-apoVs failed to do so. PBS: CP mice treated with PBS, PKM2 + :CP mice treated with PKM2 + MSC-apoVs, PKM low : CP mice treated with PKM2 low MSC-apoVs, Scale bar, 0.4 mm (microCT), 1000 μm (HE). ( b ) Quantification of periodontitis-induced alveolar bone loss, represented by measurement of palatal CEJ-ABC area (red line surrounding area). (n = 4–5) ( c and d ) Representative images and quantification of TRAP staining showed more osteoclasts (stained in red) in the PBS and PKM2 low MSC-apoV groups compared to the PKM2 + MSC-apoV group. (n = 3) Scale bar, 20 μm. ( e ) PKM2 + MSC-apoVs alleviated proinflammatory cytokines TNF-α, TNF-β, and IFN-γ. Cytokines in the plasma were analyzed using ELISA. (n = 3–4) ( f ) Flow cytometry demonstrated the ratios of Th17/Treg were decreased in peripheral blood, after treatment with PKM2 + MSC-apoVs. (n = 4–5) ( g ) HE staining demonstrated that PKM2 + MSC-apoVs alleviated pathological changes in the liver, spleen, kidneys, and femur whereas PBS and PKM2 low MSC-apoV groups did not. Scale bar, 50 μm. ( h – k ) SA-β-Gal staining and p16 IF staining revealed that PKM2 + MSC-apoVs, but not PKM2 low MSC-apoVs, reduced the accumulation of senescent cells in the liver, spleen, kidney, and femur. (n = 4) Scale bar, 50 μm (β-Gal), 200 μm (β-Gal spleen), 10 μm (IF). ( l and m ) Apoptotic levels of spleen and bone marrow were evaluated by TUNEL staining. PKM2 + MSC-apoVs increased apoptosis of spleen and bone marrow. (n = 4–5) Scale bar, 50 μm. Differences among three groups were analyzed by one-way ANOVA with Tukey's post hoc test. Error bars show the mean ± SD. ∗ P < 0.05, ∗∗ P < 0.01, ∗∗∗ P < 0.001. ns, not significant.
Techniques Used: Staining, Clinical Proteomics, Enzyme-linked Immunosorbent Assay, Flow Cytometry, TUNEL Assay

